Tag: Dr. Michael Roehrl

Oncotarget News

Behind the Study: P4HA1 Protein and Colorectal Cancer

November 22, 2021

Dr. Michael Roehrl from Memorial Sloan Kettering Cancer Center describes the research paper he co-authored that was published by Oncotarget on February 25, 2020, entitled, “Prolyl 4-hydroxylase... read more

Oncotarget

Testimonial: Dr. Michael Roehrl

November 19, 2021

Dr. Michael Roehrl from the Department of Pathology, Memorial Sloan Kettering Cancer Center discusses his experience while publishing the paper, “Prolyl 4-hydroxylase alpha 1 protein expression risk-stratifies early stage colorectal... read more